Josh Ofman
Josh Ofman, M.D., is the president of GRAIL, Inc., a biotechnology company focused on early cancer detection; he commented on the transformative potential of the Galleri blood test in cancer screening, highlighting its ability to detect new cancers at early stages and guide efficient diagnostic workups.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Josh Ofman, M.D., commented that adding Galleri to standard screening can help target new cancers in early stages.
8